ClinVar Genomic variation as it relates to human health
NM_000304.4(PMP22):c.47T>C (p.Leu16Pro)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000304.4(PMP22):c.47T>C (p.Leu16Pro)
Variation ID: 8428 Accession: VCV000008428.8
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 17p12 17: 15260681 (GRCh38) [ NCBI UCSC ] 17: 15163998 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Feb 14, 2024 Jul 11, 2019 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000304.4:c.47T>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000295.1:p.Leu16Pro missense NM_001281455.2:c.47T>C NP_001268384.1:p.Leu16Pro missense NM_001281456.2:c.47T>C NP_001268385.1:p.Leu16Pro missense NM_001330143.2:c.47T>C NP_001317072.1:p.Leu16Pro missense NM_153321.3:c.47T>C NP_696996.1:p.Leu16Pro missense NM_153322.3:c.47T>C NP_696997.1:p.Leu16Pro missense NC_000017.11:g.15260681A>G NC_000017.10:g.15163998A>G NG_007949.1:g.9647T>C LRG_263:g.9647T>C LRG_263t1:c.47T>C Q01453:p.Leu16Pro - Protein change
- L16P
- Other names
- -
- Canonical SPDI
- NC_000017.11:15260680:A:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
PMP22 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
409 | 527 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (2) |
no assertion criteria provided
|
May 1, 1993 | RCV000008940.7 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jul 11, 2019 | RCV000685070.6 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jul 11, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Charcot-Marie-Tooth disease, type I
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000812542.5
First in ClinVar: Oct 10, 2018 Last updated: Feb 14, 2024 |
Comment:
This variant has been reported to be de novo in an individual affected with¬†Charcot-Marie-Tooth disease, type 1 (CMT1) (PMID: 8995589) and has been reported to … (more)
This variant has been reported to be de novo in an individual affected with Charcot-Marie-Tooth disease, type 1 (CMT1) (PMID: 8995589) and has been reported to segregate with CMT1 in affected families (PMID: 8995589, 1303281). It has also been reported in an unrelated individual affected with CMT1 (PMID: 23689413). ClinVar contains an entry for this variant (Variation ID: 8428). This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with proline at codon 16 of the PMP22 protein (p.Leu16Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. Experimental studies have shown that this missense change results in an unstable, improperly folded and mislocalized protein (PMID: 26102530, 18795802, 21827951, 25385046, 9425015). Furthermore, mouse models with this missense change recapitulate the human phenotype (PMID: 6313869, 12090404). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(May 01, 1993)
|
no assertion criteria provided
Method: literature only
|
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000029150.4
First in ClinVar: Apr 04, 2013 Last updated: May 19, 2019 |
Comment on evidence:
Valentijn et al. (1992) demonstrated a mutation leading to the substitution of proline for leucine in the first putative transmembrane domain of PMP22 as the … (more)
Valentijn et al. (1992) demonstrated a mutation leading to the substitution of proline for leucine in the first putative transmembrane domain of PMP22 as the cause of Charcot-Marie-Tooth disease type 1A (CMT1A; 118220) in a Dutch kindred. A T-to-C transition at position 96 was responsible for the leu16-to-pro (L16P) substitution. The identical mutation had been identified in the 'Trembler-J' mouse, a homolog of the human disease. Thus, either duplication or point mutation in the PMP22 gene can result in CMT1A. Hoogendijk et al. (1993) had previously shown that the clinical disorder in this family was tightly linked to a probe on 17p11.2. The histopathologic abnormalities in nerve biopsies of patients from this family were unusually severe (Gabreels-Festen et al., 1992). Hoogendijk et al. (1993) commented that, according to the clinical, neurophysiologic, and morphologic criteria used by some investigators, most of the patients in this family would individually be given a diagnosis of hereditary motor and sensory neuropathy type III (HMSN3; 145900). (less)
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Charcot-Marie-Tooth disease, type IA
Affected status: not provided
Allele origin:
unknown
|
GeneReviews
Accession: SCV000055666.2
First in ClinVar: Apr 04, 2013 Last updated: Oct 01, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Conformational Stability and Pathogenic Misfolding of the Integral Membrane Protein PMP22. | Schlebach JP | Journal of the American Chemical Society | 2015 | PMID: 26102530 |
Charcot-Marie-Tooth Neuropathy Type 1 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. | Adam MP | - | 2015 | PMID: 20301384 |
Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease. | Hara T | Scientific reports | 2014 | PMID: 25385046 |
Proptosis in a family with the p16 Leuc-to-Prol mutation in the PMP22 gene (CMT 1E). | Calia L | Arquivos de neuro-psiquiatria | 2013 | PMID: 23689413 |
Structural basis for the Trembler-J phenotype of Charcot-Marie-Tooth disease. | Sakakura M | Structure (London, England : 1993) | 2011 | PMID: 21827951 |
The peripheral neuropathy-linked Trembler and Trembler-J mutant forms of peripheral myelin protein 22 are folding-destabilized. | Myers JK | Biochemistry | 2008 | PMID: 18795802 |
Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. | Robertson AM | Journal of anatomy | 2002 | PMID: 12090404 |
Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. | D'Urso D | The Journal of neuroscience : the official journal of the Society for Neuroscience | 1998 | PMID: 9425015 |
Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. | Ionasescu VV | Muscle & nerve | 1997 | PMID: 8995589 |
Allelic heterogeneity in hereditary motor and sensory neuropathy type Ia (Charcot-Marie-Tooth disease type 1a). | Hoogendijk JE | Neurology | 1993 | PMID: 8492918 |
Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I). | Gabreëls-Festen AA | Journal of the neurological sciences | 1992 | PMID: 1564512 |
Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. | Valentijn LJ | Nature genetics | 1992 | PMID: 1303281 |
Comparison of Trembler and Trembler-J mouse phenotypes: varying severity of peripheral hypomyelination. | Henry EW | Journal of neuropathology and experimental neurology | 1983 | PMID: 6313869 |
click to load more click to collapse |
Text-mined citations for rs104894617 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.